These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 25564664)

  • 41. Ascochlorin is a novel, specific inhibitor of the mitochondrial cytochrome bc1 complex.
    Berry EA; Huang LS; Lee DW; Daldal F; Nagai K; Minagawa N
    Biochim Biophys Acta; 2010 Mar; 1797(3):360-70. PubMed ID: 20025846
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Resistance mutations reveal the atovaquone-binding domain of cytochrome b in malaria parasites.
    Srivastava IK; Morrisey JM; Darrouzet E; Daldal F; Vaidya AB
    Mol Microbiol; 1999 Aug; 33(4):704-11. PubMed ID: 10447880
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative kinetics of Qi site inhibitors of cytochrome bc1 complex: picomolar antimycin and micromolar cyazofamid.
    Li H; Zhu XL; Yang WC; Yang GF
    Chem Biol Drug Des; 2014 Jan; 83(1):71-80. PubMed ID: 23919901
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Computational discovery of picomolar Q(o) site inhibitors of cytochrome bc1 complex.
    Hao GF; Wang F; Li H; Zhu XL; Yang WC; Huang LS; Wu JW; Berry EA; Yang GF
    J Am Chem Soc; 2012 Jul; 134(27):11168-76. PubMed ID: 22690928
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A comparison of stigmatellin conformations, free and bound to the photosynthetic reaction center and the cytochrome bc1 complex.
    Lancaster CR; Hunte C; Kelley J; Trumpower BL; Ditchfield R
    J Mol Biol; 2007 Apr; 368(1):197-208. PubMed ID: 17337272
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modeling the molecular basis of atovaquone resistance in parasites and pathogenic fungi.
    Kessl JJ; Meshnick SR; Trumpower BL
    Trends Parasitol; 2007 Oct; 23(10):494-501. PubMed ID: 17826334
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Crystallographic studies of quinol oxidation site inhibitors: a modified classification of inhibitors for the cytochrome bc(1) complex.
    Esser L; Quinn B; Li YF; Zhang M; Elberry M; Yu L; Yu CA; Xia D
    J Mol Biol; 2004 Jul; 341(1):281-302. PubMed ID: 15312779
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The cytochrome b lysine 329 residue is critical for ubihydroquinone oxidation and proton release at the Q
    Francia F; Khalfaoui-Hassani B; Lanciano P; Musiani F; Noodleman L; Venturoli G; Daldal F
    Biochim Biophys Acta Bioenerg; 2019 Feb; 1860(2):167-179. PubMed ID: 30550726
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ubiquinol oxidation in the cytochrome bc1 complex: reaction mechanism and prevention of short-circuiting.
    Mulkidjanian AY
    Biochim Biophys Acta; 2005 Aug; 1709(1):5-34. PubMed ID: 16005845
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mitochondrial type II NADH dehydrogenase of Plasmodium falciparum (PfNDH2) is dispensable in the asexual blood stages.
    Ke H; Ganesan SM; Dass S; Morrisey JM; Pou S; Nilsen A; Riscoe MK; Mather MW; Vaidya AB
    PLoS One; 2019; 14(4):e0214023. PubMed ID: 30964863
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cyclization-blocked proguanil as a strategy to improve the antimalarial activity of atovaquone.
    Skinner-Adams TS; Fisher GM; Riches AG; Hutt OE; Jarvis KE; Wilson T; von Itzstein M; Chopra P; Antonova-Koch Y; Meister S; Winzeler EA; Clarke M; Fidock DA; Burrows JN; Ryan JH; Andrews KT
    Commun Biol; 2019; 2():166. PubMed ID: 31069275
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis and structure-activity relationships of 4-pyridones as potential antimalarials.
    Yeates CL; Batchelor JF; Capon EC; Cheesman NJ; Fry M; Hudson AT; Pudney M; Trimming H; Woolven J; Bueno JM; Chicharro J; Fernández E; Fiandor JM; Gargallo-Viola D; Gómez de las Heras F; Herreros E; León ML
    J Med Chem; 2008 May; 51(9):2845-52. PubMed ID: 18396855
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interactions between the cytochrome b, cytochrome c1, and Fe-S protein subunits at the ubihydroquinone oxidation site of the bc1 complex of Rhodobacter capsulatus.
    Saribaş AS; Valkova-Valchanova M; Tokito MK; Zhang Z; Berry EA; Daldal F
    Biochemistry; 1998 Jun; 37(22):8105-14. PubMed ID: 9609705
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Computation-based virtual screening for designing novel antimalarial drugs by targeting falcipain-III: a structure-based drug designing approach.
    Kesharwani RK; Singh DV; Misra K
    J Vector Borne Dis; 2013; 50(2):93-102. PubMed ID: 23995310
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Saccharomyces cerevisiae-based mutational analysis of the bc1 complex Qo site residue 279 to study the trade-off between atovaquone resistance and function.
    Song Z; Clain J; Iorga BI; Yi Z; Fisher N; Meunier B
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4053-8. PubMed ID: 25918152
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cytochrome bc1 complex [2Fe-2S] cluster and its interaction with ubiquinone and ubihydroquinone at the Qo site: a double-occupancy Qo site model.
    Ding H; Robertson DE; Daldal F; Dutton PL
    Biochemistry; 1992 Mar; 31(12):3144-58. PubMed ID: 1313287
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Generation of quinolone antimalarials targeting the Plasmodium falciparum mitochondrial respiratory chain for the treatment and prophylaxis of malaria.
    Biagini GA; Fisher N; Shone AE; Mubaraki MA; Srivastava A; Hill A; Antoine T; Warman AJ; Davies J; Pidathala C; Amewu RK; Leung SC; Sharma R; Gibbons P; Hong DW; Pacorel B; Lawrenson AS; Charoensutthivarakul S; Taylor L; Berger O; Mbekeani A; Stocks PA; Nixon GL; Chadwick J; Hemingway J; Delves MJ; Sinden RE; Zeeman AM; Kocken CH; Berry NG; O'Neill PM; Ward SA
    Proc Natl Acad Sci U S A; 2012 May; 109(21):8298-303. PubMed ID: 22566611
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Primary steps in the energy conversion reaction of the cytochrome bc1 complex Qo site.
    Sharp RE; Moser CC; Gibney BR; Dutton PL
    J Bioenerg Biomembr; 1999 Jun; 31(3):225-33. PubMed ID: 10591528
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel Inhibitors for a Novel Binding Site in Respiratory Complex III.
    Hagras MA; Stuchebrukhov AA
    J Phys Chem B; 2016 Mar; 120(10):2701-8. PubMed ID: 26907223
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structural analysis of cytochrome bc1 complexes: implications to the mechanism of function.
    Xia D; Esser L; Tang WK; Zhou F; Zhou Y; Yu L; Yu CA
    Biochim Biophys Acta; 2013; 1827(11-12):1278-94. PubMed ID: 23201476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.